| Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer MP Pinto, C Balmaceda, ML Bravo, S Kato, A Villarroel, GI Owen, JC Roa, ... Gynecologic oncology 151 (1), 10-17, 2018 | 104 | 2018 |
| Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial ME Balcells, L Rojas, N Le Corre, C Martínez-Valdebenito, ME Ceballos, ... PLoS medicine 18 (3), e1003415, 2021 | 79 | 2021 |
| Costs and consequences of chronic pain due to musculoskeletal disorders from a health system perspective in Chile C Vargas, N Bilbeny, C Balmaceda, MF Rodríguez, P Zitko, R Rojas, ... Pain reports 3 (5), e656, 2018 | 72 | 2018 |
| High proportion of potential candidates for immunotherapy in a chilean cohort of gastric cancer patients: Results of the FORCE1 study M Cordova-Delgado, MP Pinto, IN Retamal, M Muñoz-Medel, ML Bravo, ... Cancers 11 (9), 1275, 2019 | 22 | 2019 |
| Early anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: a randomized phase II clinical trial ME Balcells, L Rojas, N Le Corre, C Martínez-Valdebenito, ME Ceballos, ... medRxiv, 2020.09. 17.20196212, 2020 | 21 | 2020 |
| Prevalence, burden of disease, and lost in health state utilities attributable to chronic musculoskeletal disorders and pain in Chile P Zitko, N Bilbeny, C Balmaceda, T Abbott, C Carcamo, M Espinoza BMC public health 21, 1-9, 2021 | 20 | 2021 |
| Chilean Gastric Cancer Task Force: A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients GI Owen, MP Pinto, IN Retamal, MF Fernádez, B Cisternas, S Mondaca, ... Medicine 97 (16), e0419, 2018 | 20 | 2018 |
| Impacto de una Política de Equivalencia Terapéutica en el Precio de Medicamentos en Chile C Balmaceda, MA Espinoza, J Diaz Value in Health Regional Issues 8, 43-48, 2015 | 18 | 2015 |
| Chilean registry for neuroendocrine tumors: A Latin American perspective MP Pinto, M Muñoz Medel, D Carrillo, IN Retamal, ML Bravo, ... Hormones and Cancer 10, 3-10, 2019 | 14 | 2019 |
| Gasto de bolsillo en salud y medicamentos en Chile: Análisis comparativo de los periodos 1997, 2007, y 2012 M Oyarte, M Espinoza, C Balmaceda, R Villegas, B Cabieses, J Díaz Value in health regional issues 17, 202-209, 2018 | 14 | 2018 |
| Cost analysis of chronic pain due to musculoskeletal disorders in Chile MA Espinoza, N Bilbeny, T Abbott, C Carcamo, P Zitko, P Zamorano, ... PLoS One 17 (10), e0273667, 2022 | 11 | 2022 |
| Informe del Proyecto Estudio:“Evaluación y monitoreo de suelo para el desarrollo de Tecnologías integrales y sostenibles de la Caña de Azúcar” R Villegas, C Balmaceda, D Ponce, B Leyda, R Martín Inédito. Archivo del Programa Manejo Agronómico, 34, 2003 | 10 | 2003 |
| Health state utility values of type 2 diabetes mellitus and related complications: A systematic review and meta-analysis G Redenz, MC Ibaceta, D Aceituno, C Balmaceda, MA Espinoza Value in Health Regional Issues 34, 14-22, 2023 | 6 | 2023 |
| Health and economic effects on patients with type 2 diabetes mellitus in the long run: predictions for the Chilean population MA Espinoza, T Abbott, A Passi, C Balmaceda Diabetology & Metabolic Syndrome 14 (1), 155, 2022 | 6 | 2022 |
| A model-based economic evaluation of cladribine versus alemtuzumab, ocrelizumab and natalizumab for the treatment of relapsing-remitting multiple sclerosis with high disease … MA Espinoza, R Rojas, A Zaupa, C Balmaceda PharmacoEconomics-open 5, 635-647, 2021 | 6 | 2021 |
| Analisis del proceso de evaluación de tecnologías sanitarias del sistema de protección financiera para diagnósticos y tratamientos de alto costo en Chile (Ley Ricarte Soto) N Armijo, M Espinoza, P Zamorano, D Lahoz, T Yañez, C Balmaceda Value in Health Regional Issues 32, 95-101, 2022 | 5 | 2022 |
| Estimation of the demand for palliative care in non-oncologic patients in Chile N Armijo, T Abbot, M Espinoza, X Neculhueque, C Balmaceda BMC Palliative Care 22 (1), 5, 2023 | 4 | 2023 |
| Medication review with follow-up for cardiovascular outcomes: a trial based cost–utility analysis A Ahumada-Canale, C Vargas, C Balmaceda, F Martinez-Mardones, ... Journal of Comparative Effectiveness Research 10 (3), 229-242, 2020 | 4 | 2020 |
| Economic evaluation of sunitinib versus pazopanib and best supportive care for the treatment of metastatic renal cell carcinoma in Chile: cost-effectiveness analysis and a … C Vargas, C Balmaceda, F Rodríguez, R Rojas, A Giglio, MA Espinoza Expert Review of Pharmacoeconomics & Outcomes Research 19 (5), 609-617, 2019 | 4 | 2019 |
| Out-of-pocket expenditures in health and medications in Chile: comparative analysis between 1997, 2007, and 2012 M Oyarte, M Espinoza, C Balmaceda, R Villegas, B Cabieses, J Díaz Value in Health Regional Issues 17, 202-209, 2018 | 4 | 2018 |
